Cross-site Scripting in DEXMA DEXGate
Default status is the baseline for the product, each version can override it (e.g. patched versions marked unaffected).
| Vendor | Product | Default status | Versions | ||||||
|---|---|---|---|---|---|---|---|---|---|
| DEXMA | DexGate | unaffected |
|
No data.
No data available yet.
| Source | ID | Title |
|---|---|---|
EUVD |
EUVD-2023-44760 | The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software. |
No CVSS v4.0
No CVSS v3.0
No CVSS v2
This CVE is not in the KEV list.
Exploit prediction score: < 1% (0.359% probability within 30 days)
Key SSVC decision points have not yet been added.
No history.